Company news
Proteomics International Laboratories Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Appendix 4C - March 2018 Quarterly Report
April 25, 2018
Europe PromarkerD patent granted for diabetic kidney disease
April 18, 2018
Underwriters take final $342,000 of Proteomics Options
April 16, 2018
Conversion of 90% of Proteomics Options raises of $3m
April 5, 2018
Directors Exercise PIQ Options
March 23, 2018
Proteomics secures underwriting - PIQ Options to raise $3.4m
March 13, 2018
Proteomics launches PromarkerD
March 6, 2018
Strategic alliance and investment in CPR Pharma Services
February 1, 2018
PromarkerD diabetic kidney disease patent granted in Japan
January 28, 2018
Appendix 4C - December 2017 Quarterly Report
January 25, 2018
Proteomics joins major health study to target lung disease
December 3, 2017
PromarkerD predictive diagnostic test to launch in Q1 2018
November 26, 2017
Proteomics partnered consortium to receive $2 million
October 26, 2017
Appendix 4C - September 2017 Quarterly Report
October 25, 2017
Proteomics receives R&D tax incentive
October 9, 2017
PromarkerD predictive test results published - Diabetes Care
September 6, 2017
US PromarkerD patent expanded to all kidney disease
August 16, 2017
Appendix 4C - corrected
July 28, 2017
Appendix 4C - June 2017 Quarterly Report
July 27, 2017
Proteomics wins major analytical services contract
July 14, 2017
Response to ASX Query
June 15, 2017
Clinical validation study confirms PromarkerD performance
June 12, 2017
World leading laboratory launches clinical trials testing
May 8, 2017
Appendix 4C - March 2017 Quarterly Report
April 26, 2017
PromarkerD Update
April 3, 2017
Frost & Sullivan- PromarkerD diagnostic test world leading
March 26, 2017
Proteomics targets diabetic kidney disease in Asia
March 20, 2017
Diabetic Kidney Disease Diagnostic Test Data Published
February 7, 2017
Appendix 4C - December 2016 Quarterly Report
January 24, 2017
Diabetic Kidney Disease patent granted in Russia
December 18, 2016
PromarkerD shows improved predictive ability and robustness
December 14, 2016
Proteomics completes $1.44 million Placement and offers SPP
December 1, 2016
Proteomics and Linear partner in testing and clinical trials
November 14, 2016
PromarkerD test kit production deal signed
November 10, 2016
Appendix 4C - September 2016 Quarterly Report
October 24, 2016
Proteomics targets gastro-causing parasite
October 19, 2016
Proteomics International receives FY16 R&D Tax Incentive
September 21, 2016
Proteomics investigates biomarkers for mesothelioma
September 6, 2016
Proteomics expands diagnostics portfolio to endometriosis
August 24, 2016
Proteomics first commercialisation deal for PromarkerD
August 17, 2016
Appendix 4C - June 2016 Quarterly Report
July 28, 2016
PromarkerD Development Advances in China
June 21, 2016
Decks
The 5 newest of 46 decks. Every deck is listed under its year.
- Investor Presentation (November 2026)
Investor deck · 23 slides · Nov 4, 2026
- Ignite Investment Summit (October 2026)
Conference · 25 slides · Oct 14, 2026
- Investor Presentation (September 2026)
Investor deck · 25 slides · Sep 23, 2026
- Investor Presentation (July 2026)
Investor deck · 20 slides · Jul 23, 2026
- TSN - ASX Gems Conference (December 2025)
Conference · 9 slides · Dec 19, 2025